Diagnostic Solutions for Improved Health

Zora Biosciences is a diagnostics discovery company. We identify markers of disease and develop them into robust high-throughput, value-added clinical methods.

Read more about Zora

CERT – Coronary Event Risk Test

CERT is a blood based diagnostic test that identifies patients who are at risk of heart attack or cardiovascular death. CERT helps to find high-risk patients even if their other clinical parameters such as LDL-C might suggest that they are not at an elevated risk.

Learn more about CERT

New biomarker for identification of coronary artery disease patients at high risk for cardiovascular death

Zora Biosciences in collaboration with academic research groups from Finland, Germany, Austria,  Switzerland and Norway have shown that plasma ceramides are significant predictors of cardiovascular death both in patients with stable CAD and ACS over and above currently used lipid markers such as LDL-cholesterol. This…

Read more

Zora publications

Please check our latest publications including our research on coronary event risk. The publications can be found from News - Publications.